Pro-viral integration sites for Moloney murine leukaemia virus (PIM) kinases are important target in cancer drug discovery. New lead discovery involving, in silico and ML modelling resulted imidazopyridines as new PIM-1 kinase inhibitors.
Walhekar et al. (Thu,) studied this question.